QuidelOrtho Corp(QDEL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -15.41 | Insider Own | 0.89% | Shs Outstand | 68.3M | Perf Week | -15.43% |
| Market Cap | 0.81B | Forward P/E | 8.17 | EPS next Y | 86.7% | Insider Trans | - | Shs Float | 68.0M | Perf Month | -20.57% |
| Enterprise Value | 3.76B | PEG | - | EPS next Q | 0.2 | Inst Own | 121.54% | Short Float | 20.79% | Perf Quarter | -16.39% |
| Income | -1.05B | P/S | 0.3 | EPS this Y | -63.55% | Inst Trans | -4.79% | Short Ratio | 9.57 | Perf Half Y | -34.26% |
| Sales | 2.67B | P/B | 0.45 | EPS next 5Y | -4.28% | ROA | -17.34% | Short Interest | 14.13M | Perf YTD | -58.75% |
| Book/sh | 25.99 | P/C | 6.55 | EPS past 3/5Y | - | ROE | -45.91% | 52W High | -66.89% ($35.58) | Perf Year | -60.65% |
| Cash/sh | 1.8 | P/FCF | - | Sales past 3/5Y | -5.81% 10.42% | ROIC | -23.49% | 52W Low | 18.75% ($9.92) | Perf 3Y | -84.19% |
| Dividend Est. | - | EV/EBITDA | 8.88 | EPS Y/Y TTM | -135.75% | Gross Margin | 37.68% | Volatility(W/M) | 5.9% 6.37% | Perf 5Y | -92.12% |
| Dividend TTM | - | EV/Sales | 1.41 | Sales Y/Y TTM | -2.57% | Oper. Margin | -1.16% | ATR (14) | 0.94 | Perf 10Y | -43.09% |
| Dividend Ex-Date | - | Quick Ratio | 0.76 | EPS Q/Q | 63.94% | Profit Margin | -39.21% | RSI (14) | 31.27 | Recom | 3.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.39 | Sales Q/Q | 2.45% | SMA20 | -15.91% ($14.01) | Beta | 0.78 | Target Price | $14.67 |
| Payout | - | Debt/Eq | 1.73 | Earnings | 2026/8/6 | SMA50 | -24.54% ($15.61) | Rel Volume | 0.72 | Prev Close | $12.15 |
| Employees | 6500 | LT Debt/Eq | 1.51 | EPS/Sales Surpr. | 366.39% 1.97% | SMA200 | -38.83% ($19.26) | Avg Volume(3M) | 1.48M | Price | $11.78 |
| IPO | 1991/2/1 | Option/Short | Yes/Yes | Trades | 12443 | Volume | 1,066,346 | Change | -3.05% |
Company
QDEL is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 QuidelOrtho (QDEL) is a global in vitro diagnostics company covering immunodiagnostics, molecular diagnostics, clinical chemistry, and transfusion medicine. It supplies a wide range of clinical laboratory diagnostic instruments, rapid antigen tests, and transfusion medicine solutions, with its Labs business serving as the core revenue driver. The company operates both respiratory disease testing and non-respiratory diagnostics, offering a portfolio that spans the full diagnostics landscape.
Over the past 1 year, on the lower side
67% below its 1-year high.
QDEL has weak earning power
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -63.5% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -84.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Short interest is a burden
Institutions hold 121.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHE 0.02%
MGMT 0.01%
PIPE 0.01%
PSCH 0.00%
EKG 0.00%It ranks #4 in the industry
Based on market cap of $808M.
QDEL $808M PER -
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is QDEL?
QDEL belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of QDEL?
The market cap of QDEL is approximately $808M, ranking 2,824 within its sector.
What is the 52-week high and low for QDEL?
QDEL has recorded a 52-week high of $35.58 and a low of $9.92.
